Medicare Enrolled

Dr. Oliver Freudenreich, MD

Psychiatry · Boston, MA
Consulting-driven
55 FRUIT ST, Boston, MA 02114
6179127800
In practice since 2005 (20 years)
NPI: 1710977038 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Freudenreich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Freudenreich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Freudenreich

Dr. Oliver Freudenreich is a psychiatry specialist in Boston, MA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Freudenreich received a total of $20,425 from 5 pharmaceutical and/or device companies across 21 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Freudenreich is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $20,425 industry payments

Industry Payment Transparency

Open Payments through 2021 ↗
$20,425
Total received (2018-2021)
Avg $5,106/year across 4 years
Top 5% in MA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
5
Companies
21
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,425 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$5,260
2020
$4,679
2019
$555
2018
$9,930

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$2,860
Neurocrine Biosciences, Inc.
$2,400
Top 3 companies account for 100.0% of 2021 payments
All-time payments by company (2018-2021) ›
Neurocrine Biosciences, Inc.
$10,975
Alkermes, Inc.
$5,000
Janssen Pharmaceuticals, Inc
$2,860
F. Hoffmann-La Roche AG
$1,295
Novartis Pharmaceuticals Corporation
$295
Top 3 companies account for 92.2% of all-time payments
Associated products mentioned in payments ›
Aristada 441 mg · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (100%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for psychiatry in MA.

Looking for a psychiatry specialist in Boston?
Compare psychiatrists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
2,022
Per 100K population
258.5
County median income
$92,859
Nearest hospital
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2021
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Freudenreich is a psychiatry specialist, with consulting-driven industry engagement in the top 5% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Freudenreich receive payments from pharmaceutical companies?
Yes. Dr. Freudenreich received a total of $20,425 from 5 companies across 21 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Freudenreich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in Boston
Browse psychiatrists in Boston ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in MA
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in MA
Which MA psychiatrists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Alkermes, Inc. Payments to Doctors
See all physicians who received payments from Alkermes, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →